Journal of Rheumatology

Article	Citations
Is Real-world Evidence Really Real?	66
Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain	45
Drs. Dai and Fan reply	34
50th Year of Publication: Revisiting the 1980s	32
Canadian Rheumatology Association Annual Scientific Meeting; RBC Convention Centre (and Virtually); Winnipeg, Manitoba, Canada; February 28–March 2, 2024	30
Clinical Expression of Radiographic Axial Spondyloarthritis and Its Association With HLA-B27 in European and Ibero-American Populations	28
Outcomes of Care Among Patients With Gout in Europe: A Cross-sectional Survey	28
Phase-Specific Healthcare Costs Associated With Giant Cell Arteritis in Ontario, Canada	27
“It may help you to know…”: The Early-phase Qualitative Development of a Rheumatoid Arthritis Goal Elicitation Tool	27
Follow-up Contrast-Enhanced Ultrasonography of the Carotid Artery in Patients With Takayasu Arteritis: A Retrospective Study	26
Employment and Functional Ability in Men and Women With Axial Spondyloarthritis as Described in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry	26
Remission in Gout: Concepts From a Patient Perspective	26
Young-GRAPPA (Y-GRAPPA) at the 2022 GRAPPA Annual Meeting: One Year in Y-GRAPPA. Where Do We Stand, Where Do We Go?	24
Dr. Gottlieb et al reply	24
Association Between HLA Alleles and Autoantibodies in Dermatomyositis Defined by Sarcoplasmic Expression of Myxovirus Resistance Protein A	23
A Move Toward Precision: Innovations in Measuring Spinal Mobility in Axial Spondyloarthritis	23
Factors Associated With an Electronic Health Record–Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease	23
The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort	23
Aneurysmal Disease in Patients With Takayasu Arteritis	22
“Gallia est omnis divisa in partes tres”: Social Media Platforms as a New Educational Channel for Pediatric Rheumatology	22
Arthritis Mutilans in Jo1 Antisynthetase Syndrome	22
TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition	22
Risk of Cancer Among Sarcoidosis Patients With Biopsy-verified Nonnecrotizing Granulomatous Inflammation: Population-based Cohort Study	21
The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis	21
Association of Health Literacy and Numeracy With Lupus Knowledge and the Creation of the Lupus Knowledge Assessment Test	20

Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting	20
Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND	20
OUTCOMES OF ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOUS: A SCOPING REVIEW	19
Response to Treatment With Tofacitinib in 11 Patients With Refractory Granulomatosis With Polyangiitis	19
EFAVALEUKIN ALFA IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A BAYESIAN ADAPTIVE, PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED DOSE-RANGING STUDY	18
AN UNUSUAL CASE OF LYMPHOCYTIC ENTEROCOLITIS AND VASCULITIS AS THE INITIAL MANIFESTATION OF SLE	17
PRISTANE-INDUCED LUPUS MICE PRESENT INCREASED MEGAKARYOCYTE COUNTS ALONGSIDE OTHER HISTOPATHOLOGICAL FEATURES IN THE SPLENIC TISSUE	17
ANTI-Β2GLYCOPROTEIN I-INDUCED NEUTROPHIL EXTRACELLULAR TRAPS CAUSE ENDOTHELIAL ACTIVATION	17
CONTEMPORARY KIDNEY OUTCOMES AMONG PATIENTS WITH LUPUS NEPHRITIS IN THE UNITED STATES	17
THE IMPORTANCE OF TRANS-ESOPHAGEAL ECHOCARDIOGRAPHY IN DIAGNOSING LIBMAN-SACKS ENDOCARDITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT	17
THE USE OF POLYSIMPTOMATIC DISTRESS SCALE IN A MULTICENTRIC COHORT OF SLE PATIENTS TO IDENTIFY PATIENTS WITH HIGH LEVELS TYPE 2 SYMPTOMS	16
DYSREGULATION OF THE EXPRESSION OF HUMAN RETROVIRUSES IN SYSTEMIC LUPUS ERYTHEMATOSUS	16
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist	16
DELAYED ONSET OF MALE INFERTILITY AFTER TREATMENT WITH HIGH DOSE OF CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS	16
CD38 IS OVEREXPRESSED BY IMMUNE CELLS IN CUTANEOUS LUPUS SKIN	16
The State of Patient-Reported Outcome Measures in Rheumatology	16
EFFECT OF CENERIMOD, AN S1P1 MODULATOR, ON FATIGUE IN SLE: RESULTS FROM THE PHASE 2 CARE STUDY	16
A Population-based Study of Grade 12 Academic Performance in Adolescents With Childhood-onset Chronic Rheumatic Diseases	15
A Case of Chilblains-like Lesions Post SARS-CoV-2 Vaccine?	15
Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review	15
Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use	15
A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease	14
Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib	14
Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis	14
Scrotal Calcinosis in Juvenile Systemic Sclerosis	14
Gender Differences in Disease Activity and Impact in Axial Spondyloarthritis	14
The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study	13
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus	13
Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients	13
Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation	13
Drs. Chung and McMahan reply	13
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment	12
Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus	12
Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?	12
Real-World Coverage With Influenza, Pneumococcal, and Herpes Zoster Vaccines Among Patients With Rheumatic Diseases in a Nationwide Healthcare Plan	12
Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients	12
Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus	12
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review	12
Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis: Association With Immune Activation	12
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know	12
RANDOMIZED, PLACEBO-CONTROLLED PHASE II STUDY OF ENPATORAN, A SMALL MOLECULE TOLL-LIKE RECEPTOR 7/8 INHIBITOR, IN CUTANEOUS LUPUS ERYTHEMATOSUS: RESULTS FROM COHORT A	11
SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF INDUCTION TREATMENTS FOR LUPUS NEPHRITIS	11
FACTORS INFLUENCING SUBJECTIVE MENTAL ALTERATIONS: UNRAVELING THE LUPUS BRAIN FOG	11
ASSOCIATION BETWEEN IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE OUTCOMES AND DISEASE ACTIVITY IN SLE: A REAL-WORLD COHORT STUDY	11
Spinal Stenosis Caused by Calcinosis in a Patient With Systemic Sclerosis	11
GENETICS OF EGFR VARIABILITY AS A PROXY FOR LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	11
COVID-19 BOOSTER VACCINATION, EITHER MRNA OR PROTEIN SUBUNIT VACCINES, APPEARS SAFE IN RITUXIMAB-TREATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND VASCULITIS	11
INCREASE OF IL10 AND INFA2 ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS	11
Functional Connectivity and Structural Signatures of the Visual Cortical System in Fibromyalgia: A Magnetic Resonance Imaging Study	11
SERUM NEUROFILAMENT LIGHT TO DISTINGUISH AND MONITOR ACTIVITY IN A COHORT OF NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	11

DOES SLEDAI-2K REFLECT THE INTERFERON-ALPHA GENE SIGNATURE IN SYSTEMIC LUPUS ERYTHEMATOSUS? PRELIMINARY RESULTS FROM A COHORT	11
ALL SUBCOMPONENTS OF THE CUTANEOUS LUPUS ERYTHEMATOSUS DISEASE AREA AND SEVERITY INDEX-ACTIVITY (CLASI-A) ARE RELEVANT TO IDENTIFY AND DETECT CHANGES IN SKIN ACTIVITY	11
ASSESSMENT OF FATIGUE IN A MONOCENTRIC ITALIAN COHORT OF PATIENTS AFFECTED BY SLE AND OTHER RHEUMATIC DISEASES (RDS) THROUGH VALIDATED QUESTIONNAIRES	11
The Reclassification of Patients With Previously Diagnosed Eosinophilic Granulomatosis With Polyangiitis Based on the 2022 ACR/EULAR Criteria for Antineutrophil Cytoplasmic Antibody–Associated Vasculi	11
VARIATIONS IN TACROLIMUS WHOLE BLOOD CONCENTRATIONS DURING PREGNANCY AND ITS IMPLICATIONS FOR THERAPEUTIC DRUG MONITORING: A SYSTEMATIC REVIEW AND META-ANALYSIS	10
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies	10
Formulating Knee Osteoarthritis Management Plans Taking Type 2 Diabetes Into Account: Qualitative Study of Arthritis Therapists Using Theoretical Domains Framework	10
SIMILARITY AND DIVERSITY IMMUNOLOGICAL ABERRATIONS IN STABLE BENIGN IMMUNITY AND TOWARD ANA-RELATED AUTOIMMUNE DISEASES IN ANA-POSITIVE AT-RISK POPULATIONS	10
DRUG LEVELS AND ANTI-DRUG ANTIBODIES OVER 2 YEARS OF BELIMUMAB THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS	10
CHARACTERISTICS OF NEUROLOGICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS AT A TERTIARY UNIVERSITY HOSPITAL	10
Epidemiological Characteristics of Patients With Juvenile Dermatomyositis in China: A Multicenter Study	10
ADMINISTRATION OF BELIMUMAB IN EARLY ACTIVE LUPUS PATIENTS HINDERS ACCRUAL OF EULAR/ACR CRITERIA WITHIN THE FIRST 12 MONTHS OF TREATMENT	10
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	10
THE TYPE I IFN SIGNATURE BETWEEN PATIENTS WITH RA AND SLE.	10
IMAGING INSIGHTS INTO JC VIRUS-ASSOCIATED PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN NEUROPSYCHIATRIC LUPUS: A CASE REPORT	10
An Evaluation of Burnout Among US Rheumatology Fellows: A National Survey	10
VALIDATION OF A SCORE FOR THE PREDICTION OF SERIOUS INFECTION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A LATIN AMERICAN LUPUS COHORT	10
Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series	9
Unveiling Deficiency of Adenosine Deaminase 2: An Adult Patient With Recurrent Strokes, Vasculitic Ulcers, and Bowel Perforation	9
Association Between Depressive Symptoms and Self-Reported Physical Activity in Persons With Knee Osteoarthritis	9
An Overview of Reviews to Inform Organization-Level Interventions to Address Burnout in Rheumatologists	9
Pursuing Gender Equity in Rheumatology: Thinking Beyond Gender Representation to Assess Gender Equality	9
BRIDGING THE GAP: IDENTIFYING AND ADDRESSING BARRIERS TO CARE FOR PATIENTS WITH LUPUS AND LUPUS NEPHRITIS	9
CARDIAC LUPUS: A DISEASE NOT TO BE NEGLECTED.	9
The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis	9
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study	9
The Prognostic Potential of End-Stage Knee Osteoarthritis and Its Components to Predict Knee Replacement: Data From the Osteoarthritis Initiative	9
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study	9
High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance?	9
Anxiety and Depressive Symptoms in Juvenile Idiopathic Arthritis Correlate With Pain and Stress Using PROMIS Measures	9
An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome	9
TYPE 2 LUPUS IS THE MAJOR PREDICTOR OF FATIGUE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CROSS-SECTIONAL STUDY OF 200 PATIENTS	9
ADVANCES IN TARGETED THERAPIES AND IMMUNOMODULATORY STRATEGIES IN LUPUS	9
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis	9
Advances in Psoriatic Disease Research: Insights From GRAPPA Pilot Research Awardees	9
Serum Uric Acid: A Murderer or Bystander for Cardiac-related Mortality?	9
Knowledge About Human Papillomavirus Among Patients With Immune-Mediated Inflammatory Diseases	9
Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus	9
The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases	9
VOLUME AND DYNAMIC BLOOD FLOW OF THE CHOROID PLEXUS IN NEUROINFLAMMATORY DISEASE	9
MACROPHAGE ACTIVATION SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS: REPORT OF 8 CASES	9
Association of the Apollo Wearable With Fatigue, Raynaud Phenomenon, and Quality of Life in Patients With Systemic Sclerosis: A Pilot Study	9
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment	9
IMIQUIMOD-INDUCED ONSET OF DISEASE IN LUPUS-PRONE NZB/W F1 MICE	8
Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry	8
Dr. Berti et al reply	8
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	8
Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study	8
IMPACT OF BELIMUMAB ON EFFICACY, SAFETY AND IMMUNE PHENOTYPES IN REFRACTORY AND ACTIVE LUPUS NEPHRITIS IN REAL-WORLD LOOPS REGISTRY	8
Bilateral Cricoarytenoid Joint Fixation in a Patient With Psoriasis	8
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases	8
Patient-Provider Communication in Pediatric Rheumatology: A Narrative Review and Presentation of Pilot Data	8
EXPEDITING LUPUS CLASSIFICATION OF AT-RISK INDIVIDUALS USING NOVEL TECHNOLOGY: OUTCOMES OF A PILOT STUDY	8
DOWNREGULATION OF YTHDF2 IN THE SPINAL DORSAL HORN CONTRIBUTES TO THE GENESIS OF CHRONIC PAIN INDUCED BY SYSTEMIC LUPUS ERYTHEMATOSUS	8
Infections in Vasculitis: Can We Create an Epidemic of Change?	8
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey	8
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting	8
Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events	7
A Retrospective Analysis of Outcome in Melanoma Differentiation–Associated Gene 5–Related Interstitial Lung Disease Treated with Tofacitinib or Tacrolimus	7
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study	7
DAPIROLIZUMAB PEGOL DEMONSTRATED IMPROVEMENT IN QUALITY OF LIFE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: LUPUSQOL RESULTS FROM A PHASE 3 TRIAL	7
ANIFROLUMAB EFFECTS ON RESPONSE TO INFLUENZA VACCINE IN SLE	7
Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?	7
A Frameshift Mutation ofNLRP12in a Patient With Chronic Recurrent Multifocal Osteomyelitis	7
Arthritis Mutilans in Psoriatic Arthritis: The Consequences of Delayed Treatment	7
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort	7
EFFICACY AND SAFETY OF TACROLIMUS IN THE MAINTENANCE TREATMENT OF PATIENTS WITH LUPUS NEPHRITIS	7
TRIPLE THERAPY WITH BELIMUMAB IN PROLIFERATIVE LUPUS NEPHRITIS: REAL-WORLD EFFICACY AND GLUCOCORTICOID-SPARING EFFECTS	7
REAL-WORLD EXPERIENCE OF EFFECTIVENESS OF NONMEDICAL SWITCH FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB AND BETWEEN BIOSIMILARS IN CONNECTIVE TISSUE DISEASES AND VASCULITIS	7
Patient-Reported Impact of Symptoms in Fibromyalgia (PRISM-FM)	7
Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study	7
Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study	7
PROPOSALS FOR DEFINITIONS OF MODERATE AND SEVERE DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. IMPACT ON FLARES, QUALITY OF LIFE, DAMAGE ACCRUAL, HOSPITALIZATIONS AND MORTALITY	7
The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease	7
EFFICACY AND SAFETY OF ELSUBRUTINIB AND UPADACITINIB COMBINATION AND UPADACITINIB MONOTHERAPY FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS THROUGH 104 WEEKS	7
Coexistence of Anti-Ro52 Antibodies in Anti-MDA5 Antibody–Positive Dermatomyositis Is Highly Associated With Rapidly Progressive Interstitial Lung Disease and Mortality Risk	7
Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA Study	7
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis	7
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe	7
Autoinflammatory Diseases and Vasculitis: The Missing Link	6

Patient Perspectives and Experiences With Medication for Gout: A Thematic Synthesis of Qualitative Studies	6
Optimizing Care for Pregnancy in Rheumatic Diseases: Barriers and Potential Solutions	6
Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study	6
CelebratingThe Journal of Rheumatology’s 50th Year of Publication	6
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region	6
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls	6
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies	6
Real-World Retention and Clinical Effectiveness of Secukinumab for Axial Spondyloarthritis: Results From the Canadian Spondyloarthritis Research Network	6
Complement Proteins L-Ficolin and M-Ficolin Are Increased in Patients With Axial Spondyloarthritis and Decrease After Tumor Necrosis Factor Inhibitor Treatment	6
Eosinophilic Granulomatosis With Polyangiitis With a Pathologically Proven Calcified Lung Nodule	6
A SURVEY OF PATIENTS WITH SLE SUGGESTS LIMITED KNOWLEDGE OF NEPHRITIS UNLESS THERE IS ALREADY CHRONIC KIDNEY DISEASE	6
Getting the Diagnosis Right: What’s in a Name?	6
Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody–Positive Dermatomyositis: An Observational Survey	6
Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis	6
Is the Gap in Incidence of Cardiovascular Events in Rheumatoid Arthritis Really Closing?	6
Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept	6
Does Age Matter in Psoriatic Arthritis? A Narrative Review	6
Seronegative Sjögren Syndrome: A Forgotten Entity?	6
DisseminatedMycobacterium haemophilumInfection Mimicking Rheumatoid Nodules	6
Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis	6
Type I Interferons in Autoimmunity: Implications in Clinical Phenotypes and Treatment Response	6
50 Years ofThe Journal of Rheumatology	6
Analyzing Gender Disparities in Ankylosing Spondylitis: Exploring the Factors Behind Severe Sacroiliac Joint Disease Without Spinal Involvement	6
Sociocultural and Economic Disparities in Physical Therapy Utilization Among Insured Older Adults With Rheumatoid Arthritis	6
The Road to a New Horizon in Psoriatic Arthritis	6
The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis	6
Safety and Healthcare Use Following COVID-19 Vaccination Among Adults With Rheumatoid Arthritis: A Population-Based Self-Controlled Case Series Analysis	6
NOVEL 3-BASE OLIGONUCLEOTIDE THERAPEUTIC SOF-SKN™ ANTAGONISES TLR7/8 IN AUTOIMMUNE SKIN DISEASE	5
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases	5
PROTEOMIC ANALYSIS OF SERUM OVER TIME TO FORECAST TREATMENT RESPONSE IN LUPUS NEPHRITIS	5
Brain Abscess Due toNocardiain a Patient With Systemic Lupus Erythematosus	5
Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ	5
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry	5
Clinical Heterogeneity of Patients With Antinuclear Matrix Protein 2 Antibody–Positive Myositis: A Retrospective Cohort Study in China	5
Incidence ofPneumocystis jiroveciiPneumonia and Prophylaxis-Associated Adverse Events Among Patients With Systemic Lupus Erythematosus	5
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES – THE LUPUSNET FEDERATED DATA NETWORK	5
Correlation of Fibromyalgia Survey Questionnaire and Quantitative Sensory Testing Among Patients With Active Rheumatoid Arthritis	5
REAL-WORLD ASSESSMENT OF PATTERNS OF PAIN TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: A PATHWAY VISUALIZATION STUDY USING EHR	5
ANALYSIS OF PULMONARY COMPLICATIONS IN SLE PATIENTS WITH AND WITHOUT COVID-19: A NATIONAL INPATIENT STUDY	5
EXPLORING PHYSICAL ACTIVITY ENGAGEMENT AND SUPPORT IN INDIVIDUALS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE IMPACT OF SOCIAL SUPPORT, HEALTHCARE PROVIDER RELATIONSHIPS, AND BUILT ENVIRONMENTS	5
Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry	5
AUTOIMMUNE DISEASE PREVALENCE IN PEOPLE LIVING WITH HIV AT CIPTO MANGUNKUSUMO GENERAL HOSPITAL: A COHORT STUDY	5
PARTNERING WITH ADOLESCENTS AND YOUNG ADULTS WITH CHILDHOOD-ONSET LUPUS TO IMPROVE ENGAGEMENT IN CARE	5
Using Ultrasound to Improve Diagnostic Confidence and Management of Psoriatic Disease: Highlights From the GRAPPA 2023 Ultrasound Workshop	5
50th Year of Publication: Revisiting the 1980s	5
Stressed Healthcare Systems: The Impact on the Care of Patients With Rheumatic Diseases	5
REDUCED FREQUENCY OF CIRCULATING INTERLEUKIN-16 EXPRESSING CD4+AND CD8+T CELLS ASSOCIATE WITH INCREASED URINARY IL16 LEVELS AND PROMOTE TH1 AND CD8+T CELL MIGRATION IN LUPUS PATIENTS	5
Fibromyalgia and the Difficult Synthesis	5
NONINVASIVE HIGH-THROUGHPUT SERUM PROTEOMICS FOR DISTINGUISHING SUBTYPES OF LUPUS NEPHRITIS	5
EFFECT OF COMORBIDITY AND STANDARD THERAPY ON INTERFERON STATUS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS	5
ANTI-C1Q ANTIBODIES AS INDICATORS OF DISEASE ACTIVITY, RENAL INVOLVEMENT, AND NON-SCARRING ALOPECIA IN PATIENTS WITH SLE	5
RESPONSE TO HYDROXYCHLOROQUINE IN IMMUNE THROMBOCYTOPENIA IN CHILDHOOD-ONSET SLE	5
Dose-Response Relationship Between Alcohol Consumption and Gout Risk: Do Subtypes of Alcoholic Beverages Make a Difference?	5
Cigarette Smoking Increases the Prevalence of Hip Joint Involvement in Ankylosing Spondylitis: A Real-World Case-Control Study	5
DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS	5
CLINICAL IMPACT OF C-CAR168, A NOVEL ANTI-CD20/BCMA COMPOSITE AUTOLOGOUS CAR T THERAPY, IN REFRACTORY LUPUS NEPHRITIS	5
Calcium Pyrophosphate Crystals in a Child With Wilson Disease: An Ominous Sign or Incidental Finding?	5
Adult-Onset Still Disease After ChAdOx1 nCOV-19 Vaccination	5
Acute Severe Inflammatory Lumbar Spinal Pain Induced by Calcium Pyrophosphate Crystals: Computed Tomography Is Everything	5
A EULAR/ACR (2019) SLE CLASSIFICATION CRITERIA SCORE ≥20 IS A MARKER OF SEVERE DISEASE IN A PREVALENT SLE COHORT FROM THE PORTUGUESE REUMA.PT REGISTRY	5
Degenerative Disc Disease in Young Adults With Psoriatic Arthritis	5
DEVELOPMENT OF A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) FOR THERAPEUTIC EVALUATION IN A VIRTUAL POPULATION	5
Dual-Energy Computed Tomography Has Additional Prognostic Value Over Clinical Measures in Gout Including Tophi: A Systematic Literature Review	5
Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group	5
Who Are We to Decide That the Unvaccinated Don’t Deserve Care?	4
Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden	4
Infected Tumoral Calcinosis Associated With Rheumatoid Arthritis	4
Patient Acceptable Symptom State for Burden From Appearance Changes in People With Systemic Sclerosis: A Cross-sectional Survey	4
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms	4
COMPLEMENTARY LUPUS-SPECIFIC INDEXES INFORMED BY SELECT IMMUNE MEDIATORS CHARACTERIZE RISK OF CONCURRENT DISEASE ACTIVITY AND FUTURE IMPENDING FLARE IN SYSTEMIC LUPUS ERYTHEMATOSUS	4
Online Patient-Reported Outcome Measure Engagement Is Dependent on Demographics and Locality: Findings From an Observational Cohort	4
Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody	4
SAFETY PROFILE OF VACCINES AGAINST SARS-COV-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM PROSPECTIVE MULTICENTRIC STUDY - SAFER STUDY	4
LONG-TERM OUTCOMES OF PATIENTS WITH PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (PSLE) TREATED WITH COMBINATION RITUXIMAB AND CYCLOPHOSPHAMIDE: A SINGLE-CENTER COHORT AND REVIEW OF LITERATURE	4
Rheumatoid Vasculitis–Associated Foot Gangrene	4
Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis	4
Assessing Competencies, Needs, and Satisfaction With the Transition From Pediatric to Adult Health Care in Rheumatology: Development and Validation of the Transition-KompAZ	4
Insights and Innovations: A Review of the GRAPPA 2023 Trainee Symposium	4
Acute Perimyocarditis in a Case of Multisystem Inflammatory Syndrome in Adults	4
SAFETY OF FERTILITY TREATMENTS IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: DATA FROM A FRENCH PROSPECTIVE POPULATION-BASED STUDY	4
ANTINEUTROPHIL EXTRACELLULAR TRAPS (NET) ANTIBODIES AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND SYSTEMIC LUPUS ERYTHEMATOSUS CLINICAL PHENOTYPES	4
Clinical Characteristics and Predictors of the Recurrence of Organizing Pneumonia Associated With Rheumatoid Arthritis	4
Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study	4
COMPARATIVE ANALYSIS OF BELIMUMAB, ANIFROLUMAB, AND RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A RETROSPECTIVE STUDY OF CLINICAL AND ANALYTICAL OUTCOMES	4
Microdissecting Epigenetic Pathways in Oligoarticular Juvenile Idiopathic Arthritis: A New Avenue in Transforming Growth Factor β?	4
Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status	4
IgG4-Related Arterial Disease: An Unusual Case of Aortitis	4
Sjögren Syndrome: A Forgotten or an Overdiagnosed Entity?	4
Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan	4
MRL-LPR MICE DISPLAY ALTERED NOCICEPTION: A POSSIBLE MODEL FOR LUPUS PERIPHERAL NEUROPATHY	4
INTRA-RENAL INVOLVEMENT IN PRIMARY ANTIPHOSPHOLIPID ANTIBODIES SYNDROME: DATA FROM 2 ITALIAN CENTERS	4
Long-term effectiveness and safety of denosumab for osteoporosis in patients with rheumatic diseases	4
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue With Spontaneous Shrinkage in a Patient With Sjögren Syndrome	4
A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF CB-010, A NEXT-GENERATION CRISPR-EDITED ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY, IN PATIENTS WITH REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS (GALLOP)	4
CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: PREGNANCY AND BIRTH OUTCOMES IN ONTARIO	4